JUBILANT PHARMOVA LIMITED

₹937.00
▼ ₹1.30(0.14%)
Sector:Healthcare
Industry:Pharmaceuticals & Biotechnology
Today's LowToday's High
₹918.00
₹937.00
₹941.30
2.03% to low
to high 0.46%
52W Low52W High
₹786.05
₹937.00
₹1,184.80
16.11% downside
upside 26.45%

Factor Analysis

Quantitative risk and performance factors
Quantitative risk and performance factors

Volatility

85/100

Momentum

73/100

Value

57/100

Quality

22/100

Volatility

85/100

Momentum

73/100

Value

57/100

Quality

22/100

Key Metrics

JUBLPHARMA • Latest Values

P/E

High
42.26
Price to Earnings Ratio

P/B

Fair
2.09
Price to Book Ratio

Div Yield

Low
0.53%
Annual Dividend Yield

Price

₹937.00
Latest Closing Price

P/E

High
42.26
Price to Earnings Ratio

P/B

Fair
2.09
Price to Book Ratio

Div Yield

Low
0.53%
Annual Dividend Yield

Price

₹937.00
Latest Closing Price

Performance Returns Matrix

Historical Performance
Historical Performance
1 Day
Loss
-0.14%

Normal movement

1 Week
Loss
-0.17%

Regular fluctuation

1 Month
Loss
-11.44%

Weak month

3 Months
Loss
-2.94%

Average

1 Year
Loss
-12.92%

Difficult year

3 Years
Gain
+118.98%

Strong long-term

CAGR: +29.86%
5 Years
Gain
+51.72%

Steady growth

CAGR: +8.69%
1 Day
Loss
-0.14%

Normal movement

1 Week
Loss
-0.17%

Regular fluctuation

1 Month
Loss
-11.44%

Weak month

3 Months
Loss
-2.94%

Average

1 Year
Loss
-12.92%

Difficult year

3 Years
Gain
+118.98%

Strong long-term

CAGR: +29.86%
5 Years
Gain
+51.72%

Steady growth

CAGR: +8.69%

Technical Analysis

Advanced technical indicators and patterns for in-depth analysis
Advanced technical indicators and patterns for in-depth analysis

Quantitative Data Matrix & Analysis

Advanced statistical analysis of volatility and risk-adjusted returns
Advanced statistical analysis of volatility and risk-adjusted returns

Relative Strength Matrix & Analysis

Performance comparison against market benchmark across multiple timeframes
Performance comparison against market benchmark across multiple timeframes

Z-Score Charts

Statistical deviation analysis showing how current values compare to historical averages
Statistical deviation analysis showing how current values compare to historical averages

Seasonality Analysis

Monthly return patterns and statistics
Monthly return patterns and statistics

Corporate Actions & Events

Upcoming dividends, results, and other corporate announcements
Upcoming dividends, results, and other corporate announcements

No upcoming events found

Sign Up to View Full Analysis

Get access to performance matrices, advanced technical indicators, seasonality patterns, and historical event timelines.

JUBILANT PHARMOVA LIMITED FAQs

Live market prices, valuation metrics, 52-week ranges, and financial information for JUBILANT PHARMOVA LIMITED.

What is the share price of JUBILANT PHARMOVA LIMITED today?

JUBILANT PHARMOVA LIMITED share price today is ₹937.00. The stock is currently down by 0.14% from its previous close of ₹938.30. Today’s trading range is ₹918.00 to ₹941.30.

What is the 52-week high and low of JUBILANT PHARMOVA LIMITED?

JUBILANT PHARMOVA LIMITED’s 52-week high is ₹1,184.80 and its 52-week low is ₹786.05. At the current price of ₹937.00, the stock is 20.91% below its 52-week high and 19.20% above its 52-week low.

What is the market cap of JUBILANT PHARMOVA LIMITED?

JUBILANT PHARMOVA LIMITED has a market capitalisation of approximately ₹14,842.88 crore, based on its current share price and outstanding shares. It is classified as a small-cap company.

What is the PE ratio and EPS of JUBILANT PHARMOVA LIMITED?

JUBILANT PHARMOVA LIMITED’s current P/E ratio is approximately 42.26x with an estimated trailing EPS of ₹22.17 per share.

What is the dividend yield of JUBILANT PHARMOVA LIMITED?

JUBILANT PHARMOVA LIMITED has a dividend yield of approximately 53.00% based on its latest dividend and current share price. The company paid an estimated dividend of ₹496.61 per share over the latest financial period.

What are the valuation metrics P/B and Price-to-Sales for JUBILANT PHARMOVA LIMITED?

JUBILANT PHARMOVA LIMITED currently trades at a Price-to-Book (P/B) ratio of 2.09x and a Price-to-Sales (P/S) ratio of 1.72x.